Dietrich Knauth

A U.S. federal jury sided with Reckitt Benckiser's Mead Johnson on Monday in a test trial over claims the ​company's Enfamil infant formula for preterm babies caused necrotizing enterocolitis (NEC), a ‌dangerous bowel disease.

Abbott said on Thursday it reached a $670 million settlement to partially resolve the ongoing ​litigation over alleged harms linked to its specialty formulas for preterm infants.

Abbott Laboratories has reached a settlement to resolve its appeal of a $495 million verdict over the company's specialized formula for premature infants.

Alphabet's Google is acquiring ​internal business data from bankrupt ‌Spirit Airlines for $10 million, saying it plans to use the data ​for product development and ​training its AI models.

The U.S. Court of International Trade on Thursday ruled in favor of President ‌Donald Trump's 2025 decision to rescind a "de minimis" exemption for tariffs on some imports of less than $800, a rare win for the president in the trade court's review of emergency economic powers.

A New Mexico state court ordered Meta Platforms, owner of Facebook and Instagram, to make major changes to its platforms and pay the largest sum yet in a growing wave of U.S. litigation over claims that social media harms young people.

Bayer has asked a Missouri court to reschedule a hearing to evaluate the company's $7.25 billion proposed settlement of cases alleging that its popular weedkiller Roundup causes cancer.

TikTok has agreed to settle three lawsuits brought by young people who accuse social media companies of designing their platforms to be addictive and harming their ​mental health, a plaintiffs' lawyer said Monday.

A group of 25 ​Democratic-led U.S. states sued Donald Trump's administration on Monday, arguing that the president's latest round of tariffs on goods from 60 ‌trading partners, like most of his earlier sweeping tariffs, exceeds his legal authority to tax imports.

Johnson & Johnson ​said on Monday it would pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and ‌other talc products cause ovarian cancer, in a landmark deal that could end a contentious legal battle that has dogged the company for a decade.